NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

骨移植片及替代品市場成長機會·成長預測 (2021-2028年):產品·用途·各地區

Bone Grafts and Substitutes Market by Product and Application : Global Opportunity Analysis and Industry Forecast, 2021-2028

出版商 Allied Market Research 商品編碼 1017270
出版日期 內容資訊 英文 228 Pages
商品交期: 2-3個工作天內
價格
骨移植片及替代品市場成長機會·成長預測 (2021-2028年):產品·用途·各地區 Bone Grafts and Substitutes Market by Product and Application : Global Opportunity Analysis and Industry Forecast, 2021-2028
出版日期: 2021年05月26日內容資訊: 英文 228 Pages
簡介

全球骨移植片及替代品的市場規模在預測期間內預計將以4.3%的年複合成長率推移,從2020年的26億5260萬美元,成長到2028年33億6260萬美元的規模。

肌肉骨骼疾病的增加、生物相容性人造骨的開發,醫療領域技術進步促使的自體移植向異體移植的轉變以及糖尿病和肥胖等生活方式相關疾病的增加等因素促進了該市場的成長。同時,高昂的手術成本和與植骨手術相關的倫理問題在一定程度上抑制了市場的進一步增長。

本報告提供全球骨移植片及替代品的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律規章·償付環境,市場規模的轉變·預測,類型·用途·地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義·範圍
  • 主要調查結果
  • 市場佔有率分析
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 政府法規
  • 償付方案
  • COVID-19:影響分析

第4章 市場分析·預測:各類型

  • 主要趨勢·成長要素·成長機會
  • 市場規模·預測:各地區
  • 市場分析:各國
  • 異體移植片
    • 機器加工異體移植片
    • 去礦物質骨基質(DBM)
  • 移植骨替代物
    • 骨形成蛋白(BMP)
    • 合成骨移植片
  • 細胞為基礎矩陣(CBM)

第5章 市場分析·預測:各用途

  • 脊椎融合手術
  • 外傷
  • 顱顏面外科
  • 關節重建
  • 牙科用骨移植
    • 市場規模·預測
    • 市場分析:各國

第6章 市場分析·預測:地區·各主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲
    • 主要趨勢·成長要素·成長機會
    • 市場規模·預測:各國
    • 市場規模·預測:各類型
    • 市場規模·預測:各用途

第7章 企業簡介

  • ARTHREX, INC.
  • BAXTER INTERNATIONAL INC.
  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • JOHNSON & JOHNSON(DEPUY SYNTHES)
  • MEDTRONIC PLC
  • MUSCULOSKELETAL TRANSPLANT FOUNDATION
  • NUVASIVE, INC.
  • STRYKER CORPORATION
  • XTANT MEDICAL HOLDINGS, INC.
  • ZIMMER BIOMET HOLDINGS, INC.,
目錄
Product Code: A01446

Bone grafts are implantable materials that promote bone healing through its osteoconductive, osteogenic, and osteoinductive mechanisms. The bone grafts are used in surgical procedures such as spinal fusion surgeries, bone replacement, ensuring new bone formation, and repair of bone fractures. Moreover, bone grafting has applications in the treatment of various bone related disorders such as congenital pseudoarthrosis, dental bone grafting problems, and complex fractures. Allografts, synthetic bone grafts, and demineralized bone matrix are the most commonly used bone grafts worldwide.

The global bone grafts & substitutes market was valued at $2,652.6 million in 2020, and is projected to reach $3,362.6 million by 2028, registering a CAGR of 4.3% from 2021 to 2028. Rise in incidences of musculoskeletal disorders, development of biocompatible synthetic bone grafts, technological advancements in medical field leading to a shift from autograft to allograft drive the growth of the bone grafts & substitutes market. For instance, as per the data published by World Health Organization (WHO), in 2021, musculoskeletal conditions are the prominent contributors to disability globally, with low back pain being the single primary cause of disability in 160 countries or early deaths. Low back pain causes the greatest burden with a prevalence of 568 million people and this trend is expected to continue for next few years.

In addition, increase in cases of lifestyle disorders such as diabetes and obesity add to the risk of developing degenerative joint diseases that further fuel the growth of the market. For instance, according to IDF Diabetes Atlas, Ninth Edition 2019, approximately 463 million adults had diabetes and by 2045, the number is estimated to increase to 700 million across the world. Apart from this, more than 1.1 million children were suffering from type 1 diabetes in 2019, which reveals the severity of this disease. Increase in incidences of diabetic cases leading to degenerative joint disorders is expected to provide high market growth and opportunities in near future. On the other hand, high cost of surgeries and ethical issues related with bone grafting procedures restrict the market growth. Conversely, emerging markets, rise in interests of key players toward R&D activities in bone grafts and its substitutes, and increase in demand for orthopedic procedures particularly in geriatric population are expected to provide profitable opportunities for the growth of the market in near future.

The research report categorizes the bone graft & substitute market based on product type, application, and region. By product type, it is classified into allografts, bone grafts substitutes, and cell-based matrices. The allografts are further categorized to machined allografts and demineralized bone matrix. The bone graft substitutes segment is further classified into bone morphogenic proteins (BMP) and synthetic bone grafts. By application, it is divided into spinal fusion, trauma, craniomaxilofacial, joint reconstruction, and dental bone grafting. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

This market has witnessed several product launches and approvals over the past few years. This is evident from the strategic launch of cryopreserved osteochondral allograft, ProChondrixCR by Stryker Corporate, in April 2018, while the NuVasive launched AttraX Scaffold Biologic an absorbent ceramic-collagen bone graft with an optimized surface, in June 2018. Key players profiled in this report include Arthrex, Inc., Baxter International Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson (DePuy Synthes), Medtronic Plc., Musculoskeletal Transplant Foundation, NuVasive, Inc., Stryker Corporation, Xtant Medical Holdings, Inc., Inc., and Zimmer Biomet Holdings, Inc.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis for the period of 2021-2028 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on products helps understand the type of devices used to treat musculoskeletal disorders and degenerative joints diseases.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of all geographic regions helps determine the prevailing opportunities in these regions.
  • Key market players and their strategies are analysed to understand the competitive outlook of the overall market.
  • Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS

By Product

  • Allografts
  • Machined allografts
  • Demineralized bone matrix
  • Bone Grafts Substitutes
  • Bone morphogenic proteins (BMP)
  • Synthetic bone grafts
  • Cell based matrices

By Application

  • Spinal fusion
  • Trauma
  • Craniomaxillofacial
  • Joint reconstruction
  • Dental bone grafting

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Arthrex, Inc.
  • Baxter International Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson ( DePuy Synthes )
  • Medtronic Plc.
  • Musculoskeletal Transplant Foundation
  • NuVasive, Inc.
  • Stryker Corporation
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Market share analysis, 2020
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Increase in incidences of musculoskeletal conditions
      • 3.4.1.2.Technological advancements in medical devices leading to a shift from autograft to allograft
      • 3.4.1.3.Development of biocompatible synthetic bone grafts
      • 3.4.1.4.Obesity and diabetes to increase the risk of degenerative joint diseases
    • 3.4.2.Restraints
      • 3.4.2.1.High cost of surgeries
      • 3.4.2.2.Ethical issues related with bone grafting procedures
    • 3.4.3.Opportunities
      • 3.4.3.1.Emerging markets to offer lucrative growth opportunities
  • 3.5.Government Regulations
    • 3.5.1.FDA
    • 3.5.2.Health Canada
    • 3.5.3.CE Mark
    • 3.5.4.Ministry of Health, Labor and Welfare (MHLW)
    • 3.5.5.Therapeutic Goods Administration (TGA)
  • 3.6.Reimbursement Scenario
    • 3.6.1.U.S.
    • 3.6.2.Europe
    • 3.6.3.Asia-Pacific
    • 3.6.4.LAMEA
  • 3.7.COVID-19 Impact analysis on the market

CHAPTER 4:BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Allografts
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by type
    • 4.2.3.Market size and forecast, by region
    • 4.2.4.Market analysis, by country
    • 4.2.5.Machined Allografts
      • 4.2.5.1.Market size and forecast
    • 4.2.6.Demineralized Bone Matrix (DBM)
      • 4.2.6.1.Market size and forecast
  • 4.3.Bone Graft Substitutes
    • 4.3.1.Key market trends growth factors and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market size and forecast, by region
    • 4.3.4.Market analysis, by country
    • 4.3.5.Bone Morphogenic Proteins (BMP)
      • 4.3.5.1.Market size and forecast
    • 4.3.6.Synthetic Bone Grafts
      • 4.3.6.1.Market size and forecast
  • 4.4.Cell-based Matrices (CBM)
    • 4.4.1.Key market trends, growth factors and opportunities
      • 4.4.1.1.Cell-based matrices-major products
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country

CHAPTER 5:BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Spinal Fusion
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Trauma
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Craniomaxillofacial Surgery
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Joint Reconstruction
    • 5.5.1.Market size and forecast
    • 5.5.2.Market analysis, by country
  • 5.6.Dental Bone Grafting
    • 5.6.1.Market size and forecast
    • 5.6.2.Market analysis, by country

CHAPTER 6:BONE GRAFTS & SUBSTITUTES MARKET, BY REGION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key market trends, growth factors and opportunities
    • 6.2.2.Market size and forecast, by country
      • 6.2.2.1.U.S.
      • 6.2.2.1.1.U.S. Bone grafts & substitutes market by type
      • 6.2.2.1.2.U.S. Bone grafts & substitutes market by application
      • 6.2.2.2.Canada
      • 6.2.2.2.1.Canada Bone grafts & substitutes market by type
      • 6.2.2.2.2.Canada Bone grafts & substitutes market by application
      • 6.2.2.3.Mexico
      • 6.2.2.3.1.Mexico Bone grafts & substitutes market by type
      • 6.2.2.3.2.Mexico Bone grafts & substitutes market by application
    • 6.2.3.Market size and forecast, by type
    • 6.2.4.Market size and forecast, by application
  • 6.3.Europe
    • 6.3.1.Key market trends, growth factors and opportunities
    • 6.3.2.Market size and forecast, by country
      • 6.3.2.1.Germany
      • 6.3.2.1.1.Germany Bone grafts & substitutes market by type
      • 6.3.2.1.2.Germany Bone grafts & substitutes market by application
      • 6.3.2.2.France
      • 6.3.2.2.1.France Bone grafts & substitutes market by type
      • 6.3.2.2.2.France Bone grafts & substitutes market by application
      • 6.3.2.3.Italy
      • 6.3.2.3.1.Italy Bone grafts & substitutes market by type
      • 6.3.2.3.2.Italy Bone grafts & substitutes market by application
      • 6.3.2.4.Spain
      • 6.3.2.4.1.Spain Bone grafts & substitutes market by type
      • 6.3.2.4.2.Spain Bone grafts & substitutes market by application
      • 6.3.2.5.UK
      • 6.3.2.5.1.UK Bone grafts & substitutes market by type
      • 6.3.2.5.2.UK Bone grafts & substitutes market by application
      • 6.3.2.6.Rest of Europe
      • 6.3.2.6.1.Rest of Europe Bone grafts & substitutes market by type
      • 6.3.2.6.2.Rest of Europe Bone grafts & substitutes market by application
    • 6.3.3.Market size and forecast, by type
    • 6.3.4.Market size and forecast, by application
  • 6.4.Asia-Pacific
    • 6.4.1.Key market trends, growth factors and opportunities
    • 6.4.2.Market size and forecast, by country
      • 6.4.2.1.Japan
      • 6.4.2.1.1.Japan Bone grafts & substitutes market, by type
      • 6.4.2.1.2.Japan Bone grafts & substitutes market, by application
      • 6.4.2.2.China
      • 6.4.2.2.1.China Bone grafts & substitutes market, by type
      • 6.4.2.2.2.China Bone grafts & substitutes market, by application
      • 6.4.2.3.India
      • 6.4.2.3.1.India Bone grafts & substitutes market, by type
      • 6.4.2.3.2.India Bone grafts & substitutes market, by application
      • 6.4.2.4.Australia
      • 6.4.2.4.1.Australia Bone grafts & substitutes market, by type
      • 6.4.2.4.2.Australia Bone grafts & substitutes market, by application
      • 6.4.2.5.South Korea
      • 6.4.2.5.1.South Korea Bone grafts & substitutes market, by type
      • 6.4.2.5.2.South Korea Bone grafts & substitutes market, by application
      • 6.4.2.6.Rest of Asia-Pacific
      • 6.4.2.6.1.Rest of Asia-Pacific Bone grafts & substitutes market, by type
      • 6.4.2.6.2.Rest of Asia-Pacific Bone grafts & substitutes market, by application
    • 6.4.3.Asia-Pacific Bone grafts &substitutes market, by type
    • 6.4.4.Asia-Pacific Bone grafts & substitutes market, by application
  • 6.5.LAMEA
    • 6.5.1.Key market trends, growth factors and opportunities
    • 6.5.2.Market size and forecast, by country
      • 6.5.2.1.Brazil
      • 6.5.2.1.1.Brazil bone grafts & substitutes market, by type
      • 6.5.2.1.2.Brazil bone grafts & substitutes market, by application
      • 6.5.2.2.Israel
      • 6.5.2.2.1.Israel bone grafts & substitutes market, by type
      • 6.5.2.2.2.Israel bone grafts & substitutes market, by application
      • 6.5.2.3.Saudi Arabia
      • 6.5.2.3.1.Saudi Arabia bone grafts & substitutes market, by type
      • 6.5.2.3.2.Saudi Arabia bone grafts & substitutes market, by application
      • 6.5.2.4.South Africa
      • 6.5.2.4.1.South Africa bone grafts & substitutes market, by type
      • 6.5.2.4.2.South Africa bone grafts & substitutes market, by application
      • 6.5.2.5.Rest of LAMEA
      • 6.5.2.5.1.Rest of LAMEA bone grafts & substitutes market, by type
      • 6.5.2.5.2.Rest of LAMEA bone grafts & substitutes market, by application
    • 6.5.3.Market size and forecast, by type
    • 6.5.4.Market size and forecast, by application

CHAPTER 7:COMPANY PROFILES

  • 7.1.ARTHREX, INC.
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Operating business segments
    • 7.1.4.Product Portfolio
  • 7.2.BAXTER INTERNATIONAL INC.
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Operating business segments
    • 7.2.4.Product Portfolio
    • 7.2.5.Business performance
    • 7.2.6.Key strategic moves and developments
  • 7.3.INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Operating business segments
    • 7.3.4.Product portfolio
    • 7.3.5.Business performance
  • 7.4.JOHNSON & JOHNSON (DEPUY SYNTHES)
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segments
    • 7.4.4.Product Portfolio
    • 7.4.5.Business performance
  • 7.5.MEDTRONIC PLC
    • 7.5.1.Company overview
    • 7.5.2.Company snapshot
    • 7.5.3.Operating business segments
    • 7.5.4.Product portfolio
    • 7.5.5.Business performance
    • 7.5.6.Key strategic moves and developments
  • 7.6.MUSCULOSKELETAL TRANSPLANT FOUNDATION
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Product Portfolio
  • 7.7.NUVASIVE, INC.
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Operating business segments
    • 7.7.4.Product Portfolio
    • 7.7.5.Business performance
    • 7.7.6.Key strategic moves and developments
  • 7.8.STRYKER CORPORATION
    • 7.8.1.Company overview
    • 7.8.2.Company snapshot
    • 7.8.3.Operating business segments
    • 7.8.4.Product portfolio
    • 7.8.5.Business performance
    • 7.8.6.Key strategic moves and developments
  • 7.9.XTANT MEDICAL HOLDINGS, INC.
    • 7.9.1.Company overview
    • 7.9.2.Company snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Product Portfolio
    • 7.9.5.Business performance
  • 7.10.ZIMMER BIOMET HOLDINGS, INC.,
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating business segments
    • 7.10.4.Product portfolio
    • 7.10.5.Business performance

LIST OF TABLES

  • TABLE 01.BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020 2028 ($MILLION)
  • TABLE 02.BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFT, BY TYPE 2020-2028 ($MILLION)
  • TABLE 03.BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFTS, BY REGION 2020-2028 ($MILLION)
  • TABLE 04.BONE GRAFTS & SUBSTITUTES MARKET FOR MACHINED ALLOGRAFTS, BY REGION , 2020-2028 ($MILLION)
  • TABLE 05.BONE GRAFTS & SUBSTITUTES MARKET FOR DEMINERALIZED BONE MATRIX, BY REGION, 2020-2028 ($MILLION)
  • TABLE 06.BONE GRAFTS SUBSTITUTES MARKET, BY TYPE ($MILLION), 2020-2028
  • TABLE 07.BONE GRAFTS SUBSTITUTES MARKET, BY REGION ($MILLION), 2020-2028
  • TABLE 08.BONE GRAFTS & SUBSTITUTES MARKET FOR BONE MORPHOGENETIC PROTEIN, BY REGION, 2020-2028 ($MILLION)
  • TABLE 09.BONE GRAFTS & SUBSTITUTES MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2020 & 2028 ($MILLION)
  • TABLE 10.CELL-BASED MATRICES- MAJOR PRODUCTS AND STRATEGIES
  • TABLE 11.BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY REGION, 2020 & 2028 ($MILLION)
  • TABLE 12.BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY COUNTRY, 2020 & 2028 ($MILLION),
  • TABLE 13.BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020 & 2028 ($MILLION)
  • TABLE 14.BONE GRAFTS & SUBSTITUTES MARKET FOR SPINAL FUSION, BY REGION, 2020 & 2028 ($MILLION)
  • TABLE 15.BONE GRAFTS & SUBSTITUTES MARKET FOR TRAUMA, BY REGION 2020 & 2028 ($MILLION)
  • TABLE 16.BONE GRAFTS & SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL SURGERY, BY REGION 2020 & 2028 ($MILLION)
  • TABLE 17.BONE GRAFTS & SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY REGION, 2020 & 2028 ($MILLION)
  • TABLE 18.BONE GRAFTS & SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY REGION, 2020 & 2028 ($MILLION)
  • TABLE 19.BONE GRAFTS & SUBSTITUTES MARKET, BY REGION, 2020 - 2028 ($MILLION)
  • TABLE 20.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 21.U.S. BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 22.U.S. BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 23.CANADA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 24.CANADA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 25.MEXICO BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 26.MEXICO BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 27.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
  • TABLE 28.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2021-2028 ($MILLION)
  • TABLE 29.EUROPE BONE GRAFTS & SUBSTITUTES, BY COUNTRY 2020-2028 ($MILLION)
  • TABLE 30.GERMANY BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 31.GERMANY BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 32.FRANCE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 33.FRANCE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 34.ITALY BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 35.ITALY BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 36.SPAIN BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 37.SPAIN BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 38.UK BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 39.UK BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 40.REST OF EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 41.REST OF EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 42.EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
  • TABLE 43.EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
  • TABLE 44.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 45.JAPAN BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 46.JAPAN BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 47.CHINA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 48.CHINA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 49.INDIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 50.INDIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 51.AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 52.AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 53.SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 54.SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 55.REST OF ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 56.REST OF ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 57.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 58.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
  • TABLE 59.LAMEA BONE GRAFTS & SUBSTITUTES, BY COUNTRY ($MILLION), 2020-2028
  • TABLE 60.BRAZIL BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
  • TABLE 61.BRAZIL BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
  • TABLE 62.ISRAEL BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
  • TABLE 63.ISRAEL BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2021-2028 ($MILLION)
  • TABLE 64.SAUDI ARABIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
  • TABLE 65.SAUDI ARABIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
  • TABLE 66.SOUTH AFRICA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
  • TABLE 67.SOUTH AFRICA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
  • TABLE 68.REST OF LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
  • TABLE 69.REST OF LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
  • TABLE 70.LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
  • TABLE 71.LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
  • TABLE 72.ARTHREX: COMPANY SNAPSHOT
  • TABLE 73.ARTHREX: PRODUCT CATEGORIES
  • TABLE 74.ARTHREX: PRODUCT PORTFOLIO
  • TABLE 75.BAXTER: COMPANY SNAPSHOT
  • TABLE 76.BAXTER: BUSINESS UNITS
  • TABLE 77.BAXTER: PRODUCT PORTFOLIO
  • TABLE 78.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 79.INTEGRA: COMPANY SNAPSHOT
  • TABLE 80.INTEGRA: OPERATING SEGMENTS
  • TABLE 81.INTEGRA: PRODUCT PORTFOLIO
  • TABLE 82.J&J: COMPANY SNAPSHOT
  • TABLE 83.J&J: OPERATING SEGMENTS
  • TABLE 84.J&J: PRODUCT PORTFOLIO
  • TABLE 85.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 86.MEDTRONIC: OPERATING SEGMENTS
  • TABLE 87.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 88.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89.MTF BIOLOGICS: COMPANY SNAPSHOT
  • TABLE 90.MTF BIOLOGICS: PRODUCT OFFERINGS
  • TABLE 91.MTF BIOLOGICS: PRODUCT PORTFOLIO
  • TABLE 92.NUVASIVE: COMPANY SNAPSHOT
  • TABLE 93.NUVASIVE: PRODUCT LINE
  • TABLE 94.NUVASIVE: PRODUCT PORTFOLIO
  • TABLE 95.NUVASIVE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96.STRYKER: COMPANY SNAPSHOT
  • TABLE 97.STRYKER: OPERATING SEGMENTS
  • TABLE 98.STRYKER: PRODUCT PORTFOLIO
  • TABLE 99.STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100.XTNT: COMPANY SNAPSHOT
  • TABLE 101.XTNT: OPERATING SEGMENTS
  • TABLE 102.XTNT: PRODUCT PORTFOLIO
  • TABLE 103.ZIMMER BIOMET: COMPANY SNAPSHOT
  • TABLE 104.ZIMMER BIOMET: OPERATING SEGMENTS
  • TABLE 105.ZIMMER BIOMET: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.SEGMENTATION: BONE GRAFTS & SUBSTITUTES MARKET
  • FIGURE 02.TOP INVESTMENT POCKETS: BONE GRAFTS & SUBSTITUTES MARKET
  • FIGURE 01.TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2018-2021*
  • FIGURE 02.TOP WINNING STRATEGIES: BY DEVELOPMENT, 2018-2021* (%)
  • FIGURE 03.TOP WINNING STRATEGIES: BY COMPANY, 2018-2021* (%)
  • FIGURE 01.MARKET SHARE ANALYSIS: BONE GRAFTS AND SUBSTITUTES, 2020
  • FIGURE 02.MARKET SHARE ANALYSIS: MACHINED ALLOGRAFTS, 2020
  • FIGURE 03.MARKET SHARE ANALYSIS: DEMINERALISED BONE MATRIX, 2020
  • FIGURE 04.MARKET SHARE ANALYSIS: BONE MORPHOGENIC PROTEINS, 2020
  • FIGURE 05.MARKET SHARE ANALYSIS: SYNTHETIC BONE GRAFTS, 2020
  • FIGURE 06.MARKET SHARE ANALYSIS: CELL BASED MATRICES, 2020
  • FIGURE 07.MARKET DYNAMICS
  • FIGURE 08.BONE GRAFTS & SUBSTITUTES MARKET: BY PRODUCT TYPE
  • FIGURE 09.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFTS, BY COUNTRY, 2020 & 2028(%)
  • FIGURE 10.COMPARATIVE ANALYSIS OF BONE GRAFTS SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 (%)
  • FIGURE 11.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 12.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR SPINAL FUSION, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 13.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR TRAUMA, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 14.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL SURGERY, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 15.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 16.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 17.BAXTER: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 18.BAXTER: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 19.BAXTER: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 20.INTEGRA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 21.INTEGRA: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 22.INTEGRA: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 23.J&J: REVENUE, 2018-2020 ($MILLION)
  • FIGURE 24.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 25.J&J: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 26.MEDTRONIC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 27.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 28.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 29.NUVASIVE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 30.NUVASIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 31.NUVASIVE: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 32.STRYKER: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 33.STRYKER: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 34.STRYKER: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 35.XTNT: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 36.XTNT: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 37.XTNT: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 38.ZIMMER BIOMET: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 39.ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 40.ZIMMER BIOMET: REVENUE SHARE BY REGION, 2020 (%)